マーケットレポート詳細
核酸医薬品市場：2034年予測
Nucleic Acid Therapeutics Market (Product Type: RNA interference (RNAi) and Short Interfering RNAs, Antisense Oligonucleotides (ASOs), and Others; and Application: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
- 出版元：Transparency Market Research 出版元について
- 発行年：2024年7月
- 定価：Single User License $5795 Multi User License $8795 Corporate User License $11795
- ご請求は円換算（お見積り日TTSレート）となります。
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- 納品形態：PDF by Email
- 当調査レポートは英文 195ページになります。
- 商品コード：TMR321
お問い合わせは、アイコンをクリックしてご入力ください。別タブでフォームが開きます。
当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。
レポート紹介
核酸医薬品の世界市場規模は2023年で60億ドル、2034年に221億ドル、市場の平均年成長率は12.8%にて増加する見込みです。
当レポートでは、核酸医薬品の市場予測-2034年、各種セグメント別市場分析(製品別、適応症別、国地域別、等)、パイプライン分析、PESTEL分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
■核酸医薬品の世界市場予測2020-2034年
・市場規模(US$)
■製品別、市場-2034年
・アンチセンスオリゴヌクレオチド(ASO)
・RNA干渉（RNAi）
・RNAアプタマー
※(市場規模US$)
■適応症別、市場-2034年
・自己免疫疾患
・感染症
・遺伝性疾患
・がん
・その他（神経変性疾患など）
※(市場規模US$)
■エンドユーザー別、市場-2034年
・病院
・医院
・その他（学術、研究機関など）
※(市場規模US$)
■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
■市場分析
市場ダイナミクス
パイプライン分析
PESTEL分析
ファイブフォース分析
■核酸医薬品の主要企業プロフィール動向
Alynylam Pharmaceutials, Inc.
BioNTech
Ionis Pharmaceuticals, Inc.
Moderna
日本新薬株式会社
Novartis
Pfizer
Sarepta Therapeutics
Biogen Inc.
Genzyme Sanofi
Percheron Therapeutics Ltd.
Other Prominent Players
（全195頁）
Table of Contents (英文詳細目次）
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nucleic Acid Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Regulatory Scenario by Countries
5.3. Technological Advancement
5.4. Reimbursement Scenario
5.5. PESTEL Analysis
5.6. Porter’s Five Force Analysis
5.7. Impact Analysis on Market
5.8. Investment Scenario
5.9. Unmet Needs in Current Treatment Landscape
6. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020-2034
6.3.1. Anti-Sense Oligonucleotides (ASO)
6.3.2. RNA Interference (RNAi)
6.3.3. RNA Aptamers
6.4. Market Attractiveness By Product
7. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication, 2020-2034
7.3.1. Autoimmune Disorders
7.3.2. Infectious Diseases
7.3.3. Genetic Disorders
7.3.4. Cancer
7.3.5. Others
7.4. Market Attractiveness By Indication
8. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Physicians’ Offices
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Nucleic Acid Therapeutics Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Nucleic Acid Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2020-2034
10.2.1. Anti-Sense Oligonucleotides (ASO)
10.2.2. RNA Interference (RNAi)
10.2.3. RNA Aptamers
10.3. Market Value Forecast By Indication, 2020-2034
10.3.1. Autoimmune Disorders
10.3.2. Infectious Diseases
10.3.3. Genetic Disorders
10.3.4. Cancer
10.3.5. Others
10.4. Market Value Forecast By End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Physicians’ Offices
10.4.3. Others
10.5. Market Value Forecast By Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Nucleic Acid Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2020-2034
11.2.1. Anti-Sense Oligonucleotides (ASO)
11.2.2. RNA Interference (RNAi)
11.2.3. RNA Aptamers
11.3. Market Value Forecast By Indication, 2020-2034
11.3.1. Autoimmune Disorders
11.3.2. Infectious Diseases
11.3.3. Genetic Disorders
11.3.4. Cancer
11.3.5. Others
11.4. Market Value Forecast By End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Physicians’ Offices
11.4.3. Others
11.5. Market Value Forecast By Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Nucleic Acid Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2020-2034
12.2.1. Anti-Sense Oligonucleotides (ASO)
12.2.2. RNA Interference (RNAi)
12.2.3. RNA Aptamers
12.3. Market Value Forecast By Indication, 2020-2034
12.3.1. Autoimmune Disorders
12.3.2. Infectious Diseases
12.3.3. Genetic Disorders
12.3.4. Cancer
12.3.5. Others
12.4. Market Value Forecast By End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Physicians’ Offices
12.4.3. Others
12.5. Market Value Forecast By Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Nucleic Acid Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2020-2034
13.2.1. Anti-Sense Oligonucleotides (ASO)
13.2.2. RNA Interference (RNAi)
13.2.3. RNA Aptamers
13.3. Market Value Forecast By Indication, 2020-2034
13.3.1. Autoimmune Disorders
13.3.2. Infectious Diseases
13.3.3. Genetic Disorders
13.3.4. Cancer
13.3.5. Others
13.4. Market Value Forecast By End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Physicians’ Offices
13.4.3. Others
13.5. Market Value Forecast By Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Nucleic Acid Therapeutics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2020-2034
14.2.1. Anti-Sense Oligonucleotides (ASO)
14.2.2. RNA Interference (RNAi)
14.2.3. RNA Aptamers
14.3. Market Value Forecast By Indication, 2020-2034
14.3.1. Autoimmune Disorders
14.3.2. Infectious Diseases
14.3.3. Genetic Disorders
14.3.4. Cancer
14.3.5. Others
14.4. Market Value Forecast By End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Physicians’ Offices
14.4.3. Others
14.5. Market Value Forecast By Country/Sub-region, 2020-2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Alynylam Pharmaceutials, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. BioNTech
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Ionis Pharmaceuticals, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Moderna
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Nippon Shinyaku
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Novartis
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Pfizer
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Sarepta Therapeutics
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Biogen Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Genzyme Sanofi
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Percheron Therapeutics Ltd.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
List of Tables
Table 01: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 02: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 03: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 4: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Region, 2020-2034
Table 5: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 6: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 7: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 8: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 9: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 11: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 12: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 15: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 16: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 19: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 20: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Product, 2020-2034
Table 23: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
Table 24: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Nucleic Acid Therapeutics Market Size, by Product, 2023
Figure 02: Global Nucleic Acid Therapeutics Market share (%), by Product, 2023
Figure 03: Global Nucleic Acid Therapeutics Market Size, by Indication, 2023
Figure 04: Global Nucleic Acid Therapeutics Market share (%), by Indication, 2023
Figure 05: Global Nucleic Acid Therapeutics Market Size, by End-user, 2023
Figure 06: Global Nucleic Acid Therapeutics Market share (%), by End-user, 2023
Figure 07: Global Nucleic Acid Therapeutics Market, By Region 2023 and 2034
Figure 8: Global Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast, 2020-2034
Figure 9: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
Figure 10: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023
Figure 11: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2034
Figure 12: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
Figure 13: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Anti-Sense Oligonucleotides (ASO), 2020-2034
Figure 14: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Anti-Sense Oligonucleotides (ASO), 2023 and 2034
Figure 15: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by RNA Interference (RNAi) , 2020-2034
Figure 16: Global Nucleic Acid Therapeutics Market Value Share Analysis, RNA Interference (RNAi) , 2023 and 2034
Figure 17: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by RNA Aptamers, 2020-2034
Figure 18: Global Nucleic Acid Therapeutics Market Value Share Analysis, by RNA Aptamers, 2023 and 2034
Figure 19: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
Figure 20: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023
Figure 21: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2034
Figure 22: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
Figure 23: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Autoimmune Disorders (ASO), 2020-2034
Figure 24: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Autoimmune Disorders, 2023 and 2034
Figure 25: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Infectious Diseases, 2020-2034
Figure 26: Global Nucleic Acid Therapeutics Market Value Share Analysis, Infectious Diseases, 2023 and 2034
Figure 27: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Genetic Disorders, 2020-2034
Figure 28: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Genetic Disorders, 2023 and 2034
Figure 29: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Cancer , 2020-2034
Figure 30: Global Nucleic Acid Therapeutics Market Value Share Analysis, Cancer , 2023 and 2034
Figure 31: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Others, 2020-2034
Figure 32: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Others, 2023 and 2034
Figure 33: Global Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 34: Global Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023
Figure 35: Global Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2034
Figure 36: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
Figure 37: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Hospitals, 2020-2034
Figure 38: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Hospitals, 2023 and 2034
Figure 39: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Physicians’ Offices , 2020-2034
Figure 40: Global Nucleic Acid Therapeutics Market Value Share Analysis, Physicians’ Offices , 2023 and 2034
Figure 41: Global Nucleic Acid Therapeutics Market Value (US$ Mn), by Others , 2020-2034
Figure 42: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Others , 2023 and 2034
Figure 43: Global Nucleic Acid Therapeutics Market Value Share Analysis, by Region, 2023 and 2034
Figure 44: Global Nucleic Acid Therapeutics Market Attractiveness Analysis, by Region, 2023-2034
Figure 45: North America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 46: North America Nucleic Acid Therapeutics Market Value Share Analysis, by Country, 2023 and 2034
Figure 47: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country, 2023-2034
Figure 48: North America Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
Figure 49: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
Figure 50: North America Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
Figure 51: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
Figure 52: North America Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 53: North America Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
Figure 54: Europe Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 55: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 56: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 57: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
Figure 58: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
Figure 59: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
Figure 60: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
Figure 61: Europe Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 62: Europe Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
Figure 63: Asia Pacific Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 64: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 65: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 66: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
Figure 67: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
Figure 68: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
Figure 69: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
Figure 70: Asia Pacific Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 71: Asia Pacific Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
Figure 72: Latin America Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 73: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 74: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 75: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
Figure 76: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
Figure 77: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
Figure 78: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
Figure 79: Latin America Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 80: Latin America Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034
Figure 81: Middle East & Africa Nucleic Acid Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
Figure 82: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 83: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
Figure 84: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by Product, 2023 and 2034
Figure 85: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by Product, 2023-2034
Figure 86: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by Indication, 2023 and 2034
Figure 87: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by Indication, 2023-2034
Figure 88: Middle East & Africa Nucleic Acid Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 89: Middle East & Africa Nucleic Acid Therapeutics Market Attractiveness Analysis, by End-user, 2023-2034